PAR-24-200: NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2024.
National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on July 14, 2026.
From the official notice on Grants.gov, last changed May 13, 2024. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeR25
- Clinical trialsNot allowed
- Funded byNINDS
- Median yearly award$258,602
- Typical project length5 years
- R25, Education Project. Research education programs: courses, research experiences and outreach that prepare people for research careers. Other open R25 notices.
Projects funded under PAR-24-200 were run by National Institute of Neurological Disorders and Stroke (NINDS, 8 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PAR-24-200 in the NIH Guide.
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| PAR-21-256 | July 29, 2021 | Closed July 13, 2023 | Closed |
Key dates
| Posted | May 13, 2024 |
|---|---|
| Deadline | July 14, 2026 |
| Archived by Grants.gov | August 19, 2026 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Most of the program's money (76% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NINDS R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs.
Funded under PAR-24-200 so far
NIH funded 8 projects under PAR-24-200 in fiscal 2026, at 7 institutions. The median yearly award was $258,602.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Training in Advanced Statistical Methods in Neuroimaging and Genetics | University of California Los Angeles | 2026 | $261,311 |
| Neurovascular Imaging Across Scales in Animals and Humans | Boston University (Charles River Campus) | 2026 | $250,000 |
| Neurobiology: Mechanisms and Advanced Approaches | Marine Biological Laboratory | 2026 | $265,432 |
| CSHL Course on Drosophila Neurobiology: Genes, Circuits & Behavior | Cold Spring Harbor Laboratory | 2026 | $200,900 |
| NeuroData AI Summer School: Advanced Training in Neurophysiology Data Analysis | Catalystneuro, LLC | 2026 | $137,501 |
| Men's Brain Health and Aging, Resilience & Alzheimer's Disease Career Development Program | Johns Hopkins University | 2026 | $257,389 |
| EXPanding Access to Neurosurgery reSearch Education (EXPANSE) | University of California, San Francisco | 2026 | $264,746 |
| Summer Program in Neuroscience, Excellence, and Success (SPINES) | Marine Biological Laboratory | 2026 | $259,815 |
Who has won Extramural Research Programs in the Neurosciences and Neurological Disorders grants before
From fiscal 2021 to 2025, Extramural Research Programs in the Neurosciences and Neurological Disorders (93.853) awarded $9.1 billion across 8,641 grant awards, an average of $1.0 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The General Hospital Corporation | Massachusetts | 203 | $288 million |
| The Regents of the University of California, San Francisco | California | 248 | $277 million |
| The Johns Hopkins University | Maryland | 230 | $276 million |
| The Trustees of Columbia University in the City of New York | New York | 188 | $226 million |
| Regents of the University of Michigan | Michigan | 179 | $221 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PAR-24-200 still open?
No. It closed on July 14, 2026.
Who can apply for NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)?
Closed July 14, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under PAR-24-200?
NIH RePORTER lists 8 projects funded under PAR-24-200 in fiscal 2026, at 7 institutions. The most were at Marine Biological Laboratory, University of California Los Angeles, Boston University (Charles River Campus).
Who has won Extramural Research Programs in the Neurosciences and Neurological Disorders grants before?
The largest recipients over five fiscal years were The General Hospital Corporation, The Regents of the University of California, San Francisco, The Johns Hopkins University. The program made 8,641 awards worth $9.1 billion in that time.
Similar open grants
- Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed)
- NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)
- NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)